FIERCE DRUG SAFETY WEEK
Focusing in Risk Evaluations & Mitigation Strategies And Pharmacovigilance
January 19–22, 2021
BROUGHT TO YOU BY THE TEAM BEHIND
Exploring Pharmacovigilance Strategies and Risk Mitigation Innovations to Minimize Stakeholder Risk and Improve Patient Confidence
Every pharmaceutical product has a safety and risk profile that needs to be monitored on an ongoing basis to uphold long-term safety and enhance patient care. REMS programs and pharmacovigilance strategies are an essential measure to outline how a product’s benefits outweigh its risks when administered correctly by providing up-to-date information for the efficient assessment of the risk-benefit profile of a drug, and guidance on how to mitigate major risks and avoid adverse effects.
This year’s REMS Summit will be part of Fierce’s Drug Safety Week, offering attendees 2 additional days of drug safety and pharmacovigilance-focused case studies and panel discussions on the assessment of benefit, harm, effectiveness, and risk of pharmaceuticals to patients and how these can be effectively monitored and mitigated. Some of the themes to be discussed will be, utilizing technology such as AI to improve your pharmacovigilance practices, integrating signal detection in all phases of drug development, and utilizing apps to monitor quality and compliance to improve patient outcomes, among many others.
2021 Speaker Highlight
The Fierce Difference
Partner Content Hub